{"product_id":"ausilium-miao-100-g","title":"AUXILIUM MIAO 100 G","description":"\u003ch1\u003e AUSILIUM MIAO\u003c\/h1\u003e Powdered complementary feed for cats that helps protect the urinary tract. \u003cbr\u003eIndicated as a complementary remedy for cystitis and other urinary tract infections, it is particularly effective against Escherichia coli, Klebsiella, Enterococcus faecalis, Streptococcus, Staphylococcus, Proteus, Pseudomonas, and other fimbriated bacteria. Unlike antibiotic therapy, the bacteria are not killed, but rather eliminated mechanically, washed out with the urine flow. This prevents damage to the physiological bacterial flora, a precious ally of the animal's health.\u003cbr\u003e AUSILIUM MIAO can be taken in cases of recurrent and relapsing cystitis, both during acute phases and as a preventative measure.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eIngredients\u003c\/b\u003e\u003cbr\u003e Maltodextrin, Pork liver meal, D-Mannose.\u003cbr\u003e Botanically defined natural products: Morinda citrifolia L. extract 70,000 mg.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eHow to use\u003c\/b\u003e\u003cbr\u003e Mix the powder into the usual wet food ration according to the following daily dosage: \u003cbr\u003e- up to 10 kg of weight: 2 scoops per day, in two administrations, for a total of 3 g;\u003cbr\u003e - over 10 kg in weight: 4 scoops per day, in two administrations, for a total of 6 g.\u003cbr\u003e For prevention and maintenance purposes, half the dosage will be sufficient.\u003cbr\u003e If feeding exclusively dry food, slightly moisten the food to allow the powder to adhere well and ensure complete absorption.\u003cbr\u003e It is advisable to carry out a 10-15 day administration cycle, which can be repeated if necessary at the discretion of the veterinarian.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eWarnings\u003c\/b\u003e\u003cbr\u003e Product for veterinary use only. Keep out of reach of children.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eConservation\u003c\/b\u003e\u003cbr\u003e Store in a dry place away from light.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eFormat\u003c\/b\u003e\u003cbr\u003e 100g pack.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eCod.\u003c\/b\u003e PT267\u003cbr\u003e\u003cbr\u003e \u003cu\u003eBibliography\u003c\/u\u003e :\u003cbr\u003e 1. Abgottspon D, Rabbani S, Herold J, Jiang X, Ernst B. \u003ci\u003eFimH antagonists for the oral treatment of urinary tract infection: from design and synthesis to in vitro and in vivo evaluation\u003c\/i\u003e . Klein J Med Chem Dec 2010;53:8627-41. \u003cbr\u003e2. Akihisa T, Matsumoto K, Tokuda H. \u003ci\u003eAnti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni)\u003c\/i\u003e . J Nat Prod 2007;70:754-7.\u003cbr\u003e 3. Alitheen NB, Manaf AA, Yeap SK. \u003ci\u003eImmunomodularory effects of Damnacanthal isolated from roots of Morinda elliptica\u003c\/i\u003e . Pharm Biol 2010;48:446-52.\u003cbr\u003e 4. Altarac S, Papes D. \u003ci\u003eUse of d-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women\u003c\/i\u003e . BJU Int 2014;113:9-10.\u003cbr\u003e 5. \u003ci\u003eAmerican Chemical Society. Noni plant may yield new drugs to fiht tuberculosis\u003c\/i\u003e . Press Releases at the 2000 International Chemical Congress of Pacifi Basin Societies.\u003cbr\u003e 6. Crepin S, Houle S, Carbanneau ME', Mourez M, Harel J, Dozois CM. \u003ci\u003eDecreased expression of type 1 fibriae by a pst mutant of uropathogenic Escherichia urinary tract infection: contribution to intracellular biofilm development\u003c\/i\u003e . Virulence 2010;1:333-7. \u003cbr\u003e7. Cusumano CK, Pinkner JS, Han Z, Handerson JP, Croweley JR, Hultgren SJ. \u003ci\u003eTreatment and prevention of urinary tract infection with orally active FimH inhibitors\u003c\/i\u003e . Sci Transl Med Nov 2011;3:109-15.\u003cbr\u003e 8. Gupta RK, Banerjee A, Pathak S. \u003ci\u003eInduction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells\u003c\/i\u003e . Asian Pac J Cancer Prev 2013;14:237-42.\u003cbr\u003e 9. Gupta RK, Patel AK. \u003ci\u003eDo the health claims made for Morinda citrifolia (Noni) harmonize with current scientific knowledge and evaluation of its biological effects\u003c\/i\u003e . Asian Pac J Canc Prev 2013;14:147-49.\u003cbr\u003e 10. Heinicke R. \u003ci\u003eThe Xeronine system: a new cellular mechanism that explains the health promoting action of NONI and Bromelain\u003c\/i\u003e . Direct Source Pub 2001.\u003cbr\u003e 11. Jiang X, Abgottspon D, Kleeb S, Rabbani S, Scharenberg M, Wittwer M et al. \u003ci\u003eAntiadhesion therapy for urinary tract infections--a balanced PK\/PD profile proven to be key for success\u003c\/i\u003e . J Med Chem 2012;55:4700-13. \u003cbr\u003e12. Kranjcec B, Papes D, Altarac S. \u003ci\u003eD-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial\u003c\/i\u003e . World J Urol 2013;32:79-84.\u003cbr\u003e 13. Nava CM, Ricciardo G, Valieri M. \u003ci\u003eTreatment and prevention of vaginitis recurrences\u003c\/i\u003e . Medicinae Doctor 2013 number 8.\u003cbr\u003e 14. Pawlus AD, On BN, Keller WJ. \u003ci\u003eAn anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (Noni)\u003c\/i\u003e . J Nat Prod 2005;68:1720-2.\u003cbr\u003e 15. Porru D, Parmigiani A, Tinelli C, Barletta D, Choussos D, Di Franco C, Bobbi V, Bassi S, Miller O, Gardella B, Nappi RE, Spinillo A, and Rovereto B. \u003ci\u003eOral D-mannose in recurrent urinary tract infections in women: A pilot study\u003c\/i\u003e . J Clin Urol 2014;20(10)1–6.\u003cbr\u003e 16. Pratt LA, Kolter R. \u003ci\u003eGenetic analysis of Escherichia coli biofilm formation: roles of flagellar motility, chemotaxis and type 1 pili\u003c\/i\u003e . Mol Microbiol 1998;30:285-93. \u003cbr\u003e17. Reid G, Sobel JD. \u003ci\u003eBacterial adherence in the pathogenesis of urinary tract infection: a review\u003c\/i\u003e . Clin Infect Dis 1987;9:470-87.\u003cbr\u003e 18. Sharon N. \u003ci\u003eCarbohydrates as future anti-adhesion drugs for infectious diseases\u003c\/i\u003e . Biochim Biophys Acta 2006;1760:527-37.\u003cbr\u003e 19. Umezawa K. \u003ci\u003eIsolation of 1-methoxy-2-foremyl3-hydroxyanthraquinone from M citrifolia and neoplasminhibitors containing the same\u003c\/i\u003e . Japan Kokai Tokyo Koho JP 1992;87:736(94-87, 736).\u003cbr\u003e 20. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Bouckaert J. \u003ci\u003eIntervening with urinary tract infections using anti-adhesives based on crystal structure of the FimH-ologomannose-3 complex\u003c\/i\u003e . PLoS one 2008;3:e2040.\u003cbr\u003e","brand":"DEAKOS SRL","offers":[{"title":"Default Title","offer_id":50219379818830,"sku":"925632729","price":19.62,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0845\/6214\/9710\/files\/925632729.jpg?v=1768740178","url":"https:\/\/farmaspeed.it\/en\/products\/ausilium-miao-100-g","provider":"Farmaspeed","version":"1.0","type":"link"}